These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3367936)

  • 21. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database.
    Adams PC; Gregor JC; Kertesz AE; Valberg LS
    Gastroenterology; 1995 Jul; 109(1):177-88. PubMed ID: 7797016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human leukocyte antigen typing of siblings in hereditary hemochromatosis: a cost approach.
    Adams PC; Kertesz AE
    Hepatology; 1992 Feb; 15(2):263-8. PubMed ID: 1735529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for hemochromatosis in healthy blood donors. Preliminary results.
    Edwards CQ; Griffen LM; Drummond C; Skolnick MH; Kushner JP
    Ann N Y Acad Sci; 1988; 526():258-73. PubMed ID: 3164600
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence of hemochromatosis among first-time and repeat blood donors in Norway.
    Bell H; Thordal C; Raknerud N; Hansen T; Bosnes V; Halvorsen R; Heier HE; Try K; Leivestad T; Thomassen Y
    J Hepatol; 1997 Feb; 26(2):272-9. PubMed ID: 9059946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA typing in idiopathic hemochromatosis: distinction between homozygotes and heterozygotes with biochemical expression.
    Bassett ML; Halliday JW; Powell LW
    Hepatology; 1981; 1(2):120-6. PubMed ID: 7286893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum ferritin, blood donation, iron stores and haemochromatosis.
    Worwood M; Darke C
    Transfus Med; 1993 Mar; 3(1):21-8. PubMed ID: 8038893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention.
    Powell LW; Summers KM; Board PG; Axelsen E; Webb S; Halliday JW
    Gastroenterology; 1990 Jun; 98(6):1625-32. PubMed ID: 2338199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygosity for hemochromatosis: clinical manifestations.
    Edwards CQ; Cartwright GE; Skolnick MH; Amos DB
    Ann Intern Med; 1980 Oct; 93(4):519-25. PubMed ID: 7436183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron overload in hereditary spherocytosis: association with HLA-linked hemochromatosis.
    Edwards CQ; Skolnick MH; Dadone MM; Kushner JP
    Am J Hematol; 1982 Sep; 13(2):101-9. PubMed ID: 7137169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HLA linked iron loading gene in an Afrikaner population.
    Meyer TE; Ballot D; Bothwell TH; Green A; Derman DP; Baynes RD; Jenkins T; Jooste PL; du Toit ED; Jacobs PJ
    J Med Genet; 1987 Jun; 24(6):348-56. PubMed ID: 2886665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic expression of the HLA linked iron-loading gene in males over the age of 40 years: a population study using serial serum ferritin estimations.
    Meyer T; Baynes R; Bothwell T; Jenkins T; Jooste P; Du Toit E; Martell R; Jacobs P
    J Intern Med; 1990 Jun; 227(6):397-406. PubMed ID: 1972175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing manifestations of hereditary haemochromatosis through population based screening.
    Haddow JE; Ledue TB
    J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda.
    Edwards CQ; Griffen LM; Goldgar DE; Skolnick MH; Kushner JP
    Gastroenterology; 1989 Oct; 97(4):972-81. PubMed ID: 2789160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients.
    Balan V; Baldus W; Fairbanks V; Michels V; Burritt M; Klee G
    Gastroenterology; 1994 Aug; 107(2):453-9. PubMed ID: 8039622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index.
    Summers KM; Halliday JW; Powell LW
    Hepatology; 1990 Jul; 12(1):20-5. PubMed ID: 2373481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of iron overload in central Sweden.
    Olsson KS; Ritter B; Rosén U; Heedman PA; Staugård F
    Acta Med Scand; 1983; 213(2):145-50. PubMed ID: 6837331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A screening test for detecting iron overload in population studies.
    Baynes RD; Meyer TE; Bothwell TH; McNamara L
    S Afr Med J; 1988 Aug; 74(4):167-9. PubMed ID: 3406874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population screening for haemochromatosis: a unifying analysis of published intervention trials.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):178-84. PubMed ID: 9041481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany.
    Niederau C; Niederau CM; Lange S; Littauer A; Abdel-Jalil N; Maurer M; Häussinger D; Strohmeyer G
    Ann Intern Med; 1998 Mar; 128(5):337-45. PubMed ID: 9490593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for hemochromatosis.
    Bassett ML; Halliday JW; Bryant S; Dent O; Powell LW
    Ann N Y Acad Sci; 1988; 526():274-89. PubMed ID: 3164601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.